Cancer Gene Function Shut Down by Scientists

Scientists have successfully disrupted the function of a cancer gene involved in the formation of most human tumours by tampering with the gene's on switch and growth signals. <

Scientists have successfully disrupted the function of a cancer gene involved in the formation of most human tumours by tampering with the gene's "on" switch and growth signals.

The results, achieved in multiple myeloma cells, offer a promising strategy for treating not only myeloma but also many other cancer types driven by the gene MYC, according to the study authors.

About Cancer in Women
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.

"Cancer is a disease of disregulation of growth genes in a cell, and MYC is a master regulator of these genes," said James E. Bradner, MD, of Dana-Farber Cancer Institute, one of the study's senior authors.

Previous attempts to shut down MYC by inhibiting it directly with drug molecules have been notably unsuccessful.

"In this study, our idea was to switch MYC off, interfering with its ability to activate the cell-growth program," Bradner explained.

Oral Cancer | Mouth Cancer - Types, Causes, Symptoms, Diagnosis, Treatment & Prevention
Oral cancer is a cancer that develops in any part of the mouth. It is more common in men over 40.

They did so with a small molecule called JQ1, developed by Dana-Farber's Jun Qi, PhD, and a co-author of the new study.

In myeloma, the immunoglobulin enhancers act on the out-of-place MYC gene like an impatient finger at a doorbell, repeatedly activating it.

Pancreatic Cancer - All About the Disease, its Diagnosis and Management
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.

Researchers found that the enhancers are loaded with a "bromodomain" protein called BRD4, which, they demonstrate, is used to switch on MYC.

When investigators added JQ1 to laboratory samples of myeloma cells, the bromodomain proteins fell off the enhancers and the enhancers abruptly stopped working. The result: a shutdown of MYC and a slowdown of cancer cell division.

"In a sense, the JQ1 molecule cuts the cable that activates MYC and also connects MYC to the cell-growth genes. The signal is interrupted and growth abruptly stops," Bradner said.

Their findings are being published by the journal Cell on its website Sept. 1 and in its Sept. 16 print edition.

Source-ANI